The Director, Contracting Strategy will lead the development of contracting strategies and offerings for the assigned customer segment that support brand access, business objectives, and CSL’s competitive position in the market.
The role is responsible for translating brand priorities, customer needs, reimbursement dynamics, market conditions, and customer economics into actionable contracting strategies. The Director will develop contract recommendations that balance access, volume, financial value, customer needs, operational feasibility, and enterprise objectives.
The role is a key member of the US Strategic Market Access organization and will work closely with the Senior Director, Commercial Contract Strategy and Innovation Lead, Contract Execution, Contract Operations, Pricing Operations, Price Modelling, Market Access Account, Marketing, Finance, Legal, Analytics, and other cross-functional partners to support the development, approval, implementation, and ongoing evaluation of contracting strategies.
The incumbent will possess deep expertise in pharmaceutical contracting, strong business and financial acumen, and a thorough understanding of reimbursement, customer economics, and market access within the assigned channel.
Channel Contracting Strategy:
Contract Offering Development:
Customer and Market Insights:
Brand and Access Strategy Alignment:
Financial and Business-Case Development:
Governance and Contract Approval:
Contract Implementation and Execution Support:
Contract Performance and Optimization:
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.
